Fap. Claessen et al., QUININE PHARMACOKINETICS - OTOTOXIC AND CARDIOTOXIC EFFECTS IN HEALTHY CAUCASIAN SUBJECTS AND IN PATIENTS WITH FALCIPARUM-MALARIA, TM & IH. Tropical medicine & international health, 3(6), 1998, pp. 482-489
METHOD Quinine-dihydrochloride was administered intravenously as a sin
gle dose of 300 mg to 12 healthy subjects and as multiple doses of 600
mg in 4 h every 8 h in 10 patients with falciparum malaria. Plasma qu
inine concentrations were measured by high-performance liquid chromato
graphy RESULTS Quinine pharmacokinetics are time-dependent: the appare
nt elimination halftime is shorter in the accumulation phase than in t
he elimination phase; in malaria patients the maximal quinine concentr
ation was reached in half the time calculated on the basis of the elim
ination phase after the lost quinine infusion. Nevertheless a loading
dose seemed advisable to reach adequate therapeutic levels quickly In
malaria patients the highest plasma concentrations during or at the en
d of the infusions were positively correlated with body weight. There
was no correlation between body weight and the volume of distribution
of quinine as calculated during the elimination phase. Hearing loss wa
s audiometrically documented in 9 healthy subjects at a mean maximal p
lasma quinine concentration of only 2 mg/l. All malaria patients suffe
red serious cochlear hearing impairment. The ototoxic effects in both
healthy subjects and patients appeared to be reversible. No electrogra
phic changes were noted in the healthy subjects, whereas a clinically
insignificant mean lengthening of the corrected QT interval was seen i
n the malaria patients. CONCLUSION Intravenous quinine pharmacokinetic
s in healthy Caucasians were similar to those reported for Nigerian or
Thai subjects. At effective doses quinine causes considerable but rev
ersible cochlear hearing losses in both healthy persons and in patient
s. Our findings do support the need for a loading dose. The fact that
in malaria patients there was no correlation between body weight and q
uinine VD as calculated during the elimination phase renders questiona
ble the usefulness of dosing quinine according to body weight.